期刊文献+

腺苷酸活化蛋白激酶对血管平滑肌细胞能量代谢重构调控机制研究进展 被引量:2

Research advance of regulating mechanism of adenosine monophosphate activated protein kinase on vascular smooth muscle cell energy metabolism remodeling
原文传递
导出
摘要 血管平滑肌细胞(VSMC)的异常增殖,是某些心血管疾病(如动脉粥样硬化、血管再狭窄、高血压和肺动脉高压等)共同的病理生理基础。在VSMC增殖过程中,伴随着细胞的能量代谢重构。调控VSMC能量代谢的因素有许多,如腺苷酸活化蛋白激酶(AMPK)、一氧化氮、活性氧及炎症因子等。其中,AMPK在调控能量代谢重构中起枢纽作用,多种因素可影响AMPK的表达或活性,包括遗传因素和非遗传因素。本文主要综述AMPK调控VSMC能量代谢重构作用及表观遗传因素和某些临床药物对AMPK调控的影响。 Vascular smooth muscle cells( VSMC) proliferation is a common pathophysiological basis of some cardiovascular diseases such as atherosclerosis,vascular restenosis,hypertension and pulmonary artery hypertension. Recently,studies have shown that in the process of VSMC proliferation company with cell energy metabolism remodeling. There are many factors regulating energy metabolism of VSMC,such as adenosine monophosphate activated protein kinase( AMPK),nitric oxide,reactive oxygen species and inflammation factors,etc. But AMPK plays a pivotal role in regulating the energy metabolism remodeling in VSMC proliferation. Many factors influence the expression or activity of AMPK including genetic and non-genetic factors. This paper reviews the effects of epigenetic factors and clinical drugs on the regulation of AMPK in VSMC energy metabolism remodeling.
作者 杨丽 秦旭平
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第18期1832-1836,共5页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81173060) 分子靶标新药研究协同创新项目(湘教通(2014)405号) 南华大学归国人员基金资助项目(2010XQD44)
关键词 腺苷酸活化蛋白激酶 血管平滑肌细胞 增殖 能量代谢重构 adenosine monophosphate activated protein kinase vascular smooth muscle cell proliferation energy metabolism remodeling
  • 相关文献

参考文献1

二级参考文献41

  • 1Mehta PK and Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am J Physiol Cett Physiol 2007, 292: C82-97.
  • 2Kim S and lwao H. Molecular and cellular mechanisms of angiotensin Ⅱ-mediated cardiovascular and renal diseases. Pharmacol Rev 2000. 52: 11-34.
  • 3Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y and Grant SL, et al. Novel gp91(phox) homologues in vascular smooth muscle cells : noxl mediates angiotensin lI-induced superoxide formation and redoxsensitive signaling pathways. Circ Res 2001, 88: 888-894.
  • 4Wang HD, Johns DG, Xu S and Cohen RA. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin Ⅱ. Am J Physiol Heart Circ Physiol 2002, 282:H1697-1702.
  • 5Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ and Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin 1I in mice. Circ Res 2001, 88: 947-953.
  • 6Rey FE, Cifuentes ME, Kiarash A, Quinn MT and Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Cire Res 2001, gg: 408-414. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87: 245-313.
  • 7Bedard K and Krause KH. The NOX family of ROS-genemting NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87: 245-313.
  • 8Selemidis S, Sobey CG, Wingler K, Schmidt HH and Drummond GR. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 2008, 120: 254-291.
  • 9Banff B, Molnar G, Matumna A, Steger K, Hegedus B, Demaurex N and Krause KH. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 2001, 276: 37594-37601.
  • 10Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D and Chung AB, et al. Cell transformation by the superoxide-generating oxidase Moxl. Nature 1999, 401: 79-82.

共引文献5

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部